参考文献/References:
[1]Desai SS,Achrekar SK,Paranjape SR,et al.Association ofallelic combinations of FSHR gene polymorphisms with ovarian response[J].Reprod BioMedicine Online,2013,27(4):400-406.
[2]雷媛媛,马玉涛,周连泉,等.卵泡刺激素及其受体在胃窦癌的表达及免疫荧光定位[J].解剖科学进展, 2016,22(1):13-15.
[3]Radu A,Pichon C,Camparo P,et al.Expression of follicle-stumulating hormone receptor in tumor blood vessels[J].N Engl J Med,2010,363(17):1621-1630.
[4]Gartrell BA,Tsao CK,Galsky MD.The follicle-stimulating hormone receptor: a novel target in genitourinary malignancies[J].Urol Oncol,2013,31(8):1403-1407.
[5]朱晨,杨润琳,杨敏.卵泡刺激素受体及其靶向药物的研究进展[J].肿瘤,2014,34(9):863-867.
[6]刘涛,任精华,伍钢.卵泡刺激素与肿瘤血管生成[J].国际肿瘤学杂志,2011,38(8):572-574.
[7]Grundker C,Ernst J,Reutter MD,et al.Effective targeted chem
otherapy using AEZS-108(AN-152) for LRHR receptor-positive pancreaticcancers[J].Oncol Rep,2011,26(3):629-635.
[8]袁彪,张金山,张远强,等.阿拉瑞林对GnRH受体阳性肝癌细胞Fas/FasL基因表达的影响[J].第三军医大学学报,2003,25(12):1065-1068.
[9]万美珍,周林艳,岳灵萍.GnRHR和Fas/Fasl在胃癌组织中的表达及其临床意义[J].肿瘤防治研究,2012,39(11):1382-1384.